Fact CheckerSign in

NCT05947240Completed

Effects of UE Aerobic Exercise on Exercise Capacity and PA in Patients With Pulmonary Arterial Hypertension.

Effects of Upper Extremity Aerobic Exercise on Exercise Capacity and Physical Activity in Patients With Pulmonary Arterial Hypertension.

Source: ClinicalTrials.gov · Last updated 13 Jun 2024

Brief summary (registry, in English)

Group A will be training group and group B will be control group. Deep breathing exercises will be done as baseline treatment in both groups. Both groups will be assessed with Modified Borg scale, 6-PBRT and Fatigue severity scale at the baseline. The control group patients will perform functional active alternating movements for the upper limbs at home involving three sets with 10 repetitions and a rest interval between 1- and 2-minute. Intervention will be for 3 times a week or 6 weeks. The treatment group patients will perform upper extremity aerobic exercises by using an arm ergometer under the supervision of a physiotherapist. Training intensity will adjust according to 50 80 % of max HR or intensity of dyspnea to 4 points on modified Borg scale (MBS) for at least 15 45 min, 3 times/week over 6 weeks.

Status (registry)
Completed
Study type
Interventional
Enrollment
26 (actual)
First submitted
14 Jun 2023
Start date
15 Jun 2023
Primary completion date
10 Sept 2023
Lead sponsor
Riphah International University
NCT number
NCT05947240

What you commit to

  • Study type: Interventional
  • Participants enrolled: 26
  • From 15 Jun 2023 to the primary completion date, 10 Sept 2023
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Patient with cognitive disorders.
  • Patient with orthopedic or neurological diseases. acute infection or pneumonia
  • Patient with class IV heart failure.
  • Patient with acute infection or pneumonia.

Who the study is looking for

  • Patient diagnosed with pulmonary arterial hypertension.
  • Both the sex was considered.
  • Age range from 35 to 60 years.
  • Patients who were stable.
  • Patient under optimal medical therapy for at least three months before participating in this study
  • Willing to participate in study (13).

Age in the registry: 35 years to 60 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
National hospital and Ittefaq hospital in Lahore
Coordinator of this site? Confirm its status
LahorePakistanUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.